Targeted interference with signal transduction events /
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
Berlin ; New York :
Springer,
[2007]
|
| Series: | Recent results in cancer research.
v. 172. |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Introduction: the rationale for the development of targeted drugs in cancer therapy
- Identifying critical signaling molecules for the treatment of cancer
- Tyrosine kinase inhibitors and cancer therapy
- Targeting ERBB receptors in cancer
- Inhibition of the IGF-I receptor for treatment of cancer. Kinase inhibitors and monoclonal anitbodies as alternative approaches
- Inhibition of the TGF-B signaling pathway in tumor cells
- The mammalian target of rapamycin kinase and tumor growth inhibtition
- The ras signalling pathway as a target in cancer therapy
- The mitogen-activated protein kinase pathway for molecular-targeted cancer treatment
- Clinical relevance of tareted interference with Src-mediated signal transduction events.